At a glance
- Originator Nonindustrial source
- Class Diterpenes; Furans; Small molecules
- Mechanism of Action Cholesterol ester transfer protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis
Most Recent Events
- 22 Feb 1999 New profile
- 22 Feb 1999 Preclinical development for Atherosclerosis in Japan (Unknown route)